PhD candidate at UniSA’s Applied Chemistry and Translational Biomaterials (ACTB) Group, Cintya Dharmayanti, has taken out UniSA’s 2021 Three Minute Thesis (3MT) with a condensed presentation of her research about developing nanoparticles for cancer treatment, potentially leading to more effective treatments and reduced side effects. She will be competing in the 2023 FameLab National Finals with a presentation titled, “Behind enemy lines: Tiny assassins in the war against cancer.
For more from University of South Australia visit: https://www.unisa.edu.au/connect/alumni-network/alumni-news/…Track=true.
UniSA Homepage:
https://www.unisa.edu.au/
UniSA Facebook:
https://www.facebook.com/UniSA/
https://www.facebook.com/UniSANewsroom/
UniSA Twitter:
Tweets by UniversitySA
UniSA Instagram:
https://www.instagram.com/universitysa/
Leave a reply